Literature DB >> 12534507

Indications for lymph node dissection in the treatment of extramammary Paget's disease.

Arata Tsutsumida1, Yuhei Yamamoto, Hidehiko Minakawa, Tetsunori Yoshida, Ichiro Kokubu, Tsuneki Sugihara.   

Abstract

BACKGROUND: In extramammary Paget's disease, compared with patients with carcinoma in situ (CIS), patients with malignancies underlying dermis and subcutaneous tissues or lymph node metastasis appear to have a much worse prognosis.
OBJECTIVE: The purpose was to examine our extramammary Paget's diseases patients in terms of pathological tumor invasion, lymph node metastasis, and prognosis and to refer to indications of lymph node dissection.
METHODS: The 34 patients were divided into four groups by pathological tumor invasion: CIS, microinvasion to the papillary dermis (MIPD), invasion to the reticular dermis (IRD), and invasion to subcutaneous tissues (IST). Their age, sex ratio, follow-up periods, history of other cancers, lymph node metastasis, and prognosis were compared among the four groups and referred to indications of lymph node dissection.
RESULTS: In the groups of CIS and MIPD, all patients appeared to have no lymph node metastasis and death caused by this disease. In the groups of IRD and IST, 8 of 12 patients showed pathological lymph node metastasis, and all of them died due to metastasis of the tumor. In the cumulative survival rate of the patients according to the level of invasion, 5-year survival rate was 100% in CIS and MIPD groups, 33.3% in the IRD group, and 0% in the IST group.
CONCLUSION: In the treatment of extramammary Paget's disease, indications of lymph node dissection are an important issue as well as wide local excision. From this prospective study, we have developed an algorithm for indications of lymph node dissection.

Entities:  

Mesh:

Year:  2003        PMID: 12534507     DOI: 10.1046/j.1524-4725.2003.29001.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  10 in total

Review 1.  A primer on extramammary Paget's disease for the urologist.

Authors:  Joon Yau Leong; Paul H Chung
Journal:  Transl Androl Urol       Date:  2020-02

Review 2.  Prognostic Factors of Extramammary Paget's Disease.

Authors:  Naohito Hatta
Journal:  Curr Treat Options Oncol       Date:  2018-08-15

Review 3.  Perianal Paget's disease: presentation of six cases and literature review.

Authors:  Annamaria Minicozzi; Giuseppe Borzellino; Rostand Momo; Francesca Steccanella; Federica Pitoni; Giovanni de Manzoni
Journal:  Int J Colorectal Dis       Date:  2009-08-26       Impact factor: 2.571

4.  Extramammary Paget's disease in Korea: its association with gastrointestinal neoplasms.

Authors:  Sang Nam Yoon; In Ja Park; Hee Cheol Kim; Chang Sik Yu; Mi Woo Lee; Jai Kyoung Koh; Jin Wou Kim; Young Soo Park; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2008-06-06       Impact factor: 2.571

5.  Penoscrotal Extramammary Paget's Disease with Multiple Lymph Node Metastasis.

Authors:  Yoon Taek Koo; Kyung Won Minn; Hak Chang
Journal:  Arch Plast Surg       Date:  2013-09-13

6.  Interventions for the treatment of Paget's disease of the vulva.

Authors:  Katharine A Edey; Ernest Allan; John B Murdoch; Susan Cooper; Andrew Bryant
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

7.  Perianal Extramammary Paget's Disease: More Than Meets the Eye.

Authors:  Jeff Choi; Allison Zemek; Gordon K Lee; Cindy Kin
Journal:  Dig Dis Sci       Date:  2018-11       Impact factor: 3.487

8.  Tumor Wide Horizontal Invasion Predicts Local Recurrence for Scrotal Extramammary Paget's Disease.

Authors:  Lujia Wang; Chenchen Feng; Minwei Zhou; Zhongwen Zhou; Guanxiong Ding; Peng Gao; Qiang Ding; Zhong Wu
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

9.  Mucosal Invasion, but Not Incomplete Excision, Has Negative Impact on Long-Term Survival in Patients With Extramammary Paget's Disease.

Authors:  Hiroki Hashimoto; Yumiko Kaku-Ito; Masutaka Furue; Takamichi Ito
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

10.  HER2-Targeted Antibody-Drug Conjugates Display Potent Antitumor Activities in Preclinical Extramammary Paget's Disease Models: In Vivo and Immunohistochemical Analyses.

Authors:  Keiko Tokuchi; Takuya Maeda; Shinya Kitamura; Teruki Yanagi; Hideyuki Ujiie
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.